Plain-English translation of NCT07488091 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a pilot study testing whether a multidisciplinary care program for pregnant women with sickle cell disease can be successfully delivered at a non-academic hospital in Ghana. The program brings together obstetricians, blood specialists, midwives, and other experts to provide comprehensive pregnancy care. The goal is to see if this coordinated team approach can reduce serious complications and deaths among pregnant women with sickle cell disease.
Pregnancy is extremely dangerous for women with sickle cell disease in low-resource countries like Ghana, where the risk of maternal death is about 23 times higher than for women without the disease. Currently, there are no established guidelines for how to safely manage these pregnancies in settings with limited resources. This study exists to see if a specialized team-based care program can work at regular hospitals and save lives.
You likely qualify if…
You likely don't qualify if…
You would receive your pregnancy care through the specialized multidisciplinary team at your non-academic hospital, using the same protocols that have been successful at the academic hospital. This means you would have regular prenatal visits with doctors, blood specialists, midwives, and other experts working together to monitor your health and your baby's health. You would need to commit to attending all scheduled appointments and follow-up visits for six weeks after your baby is born so the researchers can track how well the program works.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Ghana